In Development of Bio-Engineered Skin Tissue, Third Try is Charm for Advanced BioHealing

Xconomy San Diego | December 23, 2009

When it comes to commercializing a bio-engineered human skin substitute that could be used to treat diabetic ulcers and other tissue damage, Kathy McGee has the benefit of a long view.

Advanced BioHealing Commences Efficacy Trial for Dermagraft

WOUNDS | December 12, 2009

Advanced BioHealing Inc (Westport, Conn) has initiated a pivotal trial of Dermagraft® in subjects with venous leg ulcers (DEVO-Trial) to assess the product's safety and efficacy in the promotion of healing venous leg ulcers (VLUs).

How Your Small Business Can Recruit Large Company Employees

Monster.com | November 25, 2009

With millions of large-company employees pounding the pavement after recession-driven layoffs, small businesses have a recruitment opportunity that few have ever experienced.

Liquidation Preferences Creating Concern As Exit Values Fall

Wall Street Journal Blogs, Venture Capital Dispatch | November 23, 2009

Venture-backed companies with strong balance sheets are positioned to hire away people who are leaving less-desirable situations. Advanced BioHealing Inc., a profitable company that expects to roughly double sales to $80 million this year, has accelerated its hiring because of the availability of talented people.

UPDATE: Advanced BioHealing launches Dermagraft trial

MassDevice | November 18, 2009

The Westport, Conn.-based tissue regeneration company will study the effectiveness of its bio-engineering skin substitute in helping venous leg ulcers to heal, in the largest-ever randomized, controlled clinical study of bioengineered skin replacement.

Many diabetic foot amputations are preventable

Associated Press | August 25, 2009

It costs $1,400 to cover the oozing sore on the diabetic's foot with a piece of artificial skin, helping it heal if patients keep pressure off that spot. So when Medicare paid for the treatment but not the extra $100 for a simple walking cast to protect it, an artificial skin maker last year started giving free casts to some needy patients.

PDF Download |

In Vascular Disease, a Sustainable Model for Cell Therapy

Start-Up | June 15, 2009

If there’s one word that ought to sum up the goal of cell therapy today, it’s sustainability. Certainly that’s the hope of using living cells to restore health and function to diseased tissues so that they perform as the body intended them to. But more to the point, in today’stough fi nancing environment for venture-capital-backed start-ups,sustainability is the watchword for companies that have already faced, or will face in the future, 15- to 20-year development curves.

PDF Download |

The Rebirth of Dermagraft

Start-Up | February 15, 2009

The market for tissue regeneration has finally arrived, or so believes Advanced BioHealing Inc., which, on $38 millio in ventur capital from Canaan Partners, Channel Medical Partners, Red Abbey Venture Partners, Wheatley Partners, Red Abbey Venture Partners, Wheatley Partners, and Safeguard Scientifics inc., has managed to buy itself a revenue-generation tissue-engineered product and the manufacturing infrastructure to go with it. These assets will no only help the company support its own in-house development efforts on a skin replacement product, but the company also hopes to apply this specialized set of skills to other early-stage tissue engineering companies.

PDF Download |